299 related articles for article (PubMed ID: 2738447)
1. Uremic plasma after infusion of desmopressin (DDAVP) improves the interaction of normal platelets with vessel subendothelium.
Escolar G; Cases A; Monteagudo J; Garrido M; Lopez J; Ordinas A; Revert L; Castillo R
J Lab Clin Med; 1989 Jul; 114(1):36-42. PubMed ID: 2738447
[TBL] [Abstract][Full Text] [Related]
2. 1-Deamino (8-D-arginine) vasopressin infusion partially corrects platelet deposition on subendothelium in Bernard-Soulier syndrome: the role of factor VIII.
Lozano M; Escolar G; Bellucci S; Monteagudo J; Pico M; Ordinas A; Caen JP
Platelets; 1999; 10(2-3):141-5. PubMed ID: 16801084
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.
Hanebutt FL; Rolf N; Loesel A; Kuhlisch E; Siegert G; Knoefler R
Haemophilia; 2008 May; 14(3):524-30. PubMed ID: 18284449
[TBL] [Abstract][Full Text] [Related]
4. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
[TBL] [Abstract][Full Text] [Related]
5. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
[TBL] [Abstract][Full Text] [Related]
6. Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome.
Pfueller SL; Howard MA; White JG; Menon C; Berry EW
Thromb Haemost; 1987 Dec; 58(4):1060-3. PubMed ID: 3502198
[TBL] [Abstract][Full Text] [Related]
7. Desmopressin (DDAVP) enhances platelet adhesion to the extracellular matrix of cultured human endothelial cells through increased expression of tissue factor.
Gálvez A; Gómez-Ortiz G; Díaz-Ricart M; Escolar G; González-Sarmiento R; Zurbano MJ; Ordinas A; Castillo R
Thromb Haemost; 1997 May; 77(5):975-80. PubMed ID: 9184413
[TBL] [Abstract][Full Text] [Related]
8. [Shortening of acetylsalicylic acid-prolonged bleeding time by means of desmopressin].
Beck KH; Bleckmann U; Mohr P; Kretschmer V; Huss B
Beitr Infusionsther Transfusionsmed; 1994; 32():437-9. PubMed ID: 9480140
[TBL] [Abstract][Full Text] [Related]
9. Asialo von Willebrand factor enhances platelet adhesion to vessel subendothelium.
Bastida E; Monteagudo J; Ordinas A; De Marco L; Castillo R
Thromb Haemost; 1988 Aug; 60(1):30-4. PubMed ID: 3263711
[TBL] [Abstract][Full Text] [Related]
10. Shortening of bleeding time after intranasal administration of 1-deamino-8-D-arginine vasopressin to patients with chronic uremia.
Rydzewski A; Rowiński M; Myśliwiec M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):823-30. PubMed ID: 2436997
[TBL] [Abstract][Full Text] [Related]
11. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.
Casonato A; Dannhauser D; Pontara E; Bertomoro A; Orazi B; Santarossa L; Zerbinati P; Girolami A
Blood Coagul Fibrinolysis; 1996 Jul; 7(5):549-53. PubMed ID: 8874865
[TBL] [Abstract][Full Text] [Related]
12. Study on mechanisms of a haemostatic effect of 1 deamino-8-D-arginine vasopressin (desmopressin) in uraemic patients.
Malyszko J; Pietraszek M; Buczko W; Mysliwiec M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):319-24. PubMed ID: 1697836
[TBL] [Abstract][Full Text] [Related]
13. [Effect of desmopressin (DDAVP) on blood platelet parameters in vivo and in vitro].
Kätzel R; Dietzel H; Selle B; Taube C
Z Gesamte Inn Med; 1992 Jul; 47(7):303-7. PubMed ID: 1496839
[TBL] [Abstract][Full Text] [Related]
14. Laboratory response to intranasal desmopressin in women with menorrhagia and platelet dysfunction.
Rose SS; Faiz A; Miller CH; Saidi P; Philipp CS
Haemophilia; 2008 May; 14(3):571-8. PubMed ID: 18312366
[TBL] [Abstract][Full Text] [Related]
15. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.
van Vliet HH; Kappers-Klunne MC; Leebeek FW; Michiels JJ
Thromb Haemost; 2008 Sep; 100(3):462-8. PubMed ID: 18766263
[TBL] [Abstract][Full Text] [Related]
16. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous desmopressin (DDAVP) shortens the prolonged bleeding time in patients with liver cirrhosis.
Cattaneo M; Tenconi PM; Alberca I; Garcia VV; Mannucci PM
Thromb Haemost; 1990 Nov; 64(3):358-60. PubMed ID: 2096487
[TBL] [Abstract][Full Text] [Related]
18. Venostasis but not DDAVP infusion provokes the plasma fibronectin increase.
Letowska M; Bykowska K; Sablinski J; Lopaciuk S; Kopeć M
Thromb Haemost; 1990 Oct; 64(2):294-6. PubMed ID: 2270537
[TBL] [Abstract][Full Text] [Related]
19. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.
Mannucci PM; Remuzzi G; Pusineri F; Lombardi R; Valsecchi C; Mecca G; Zimmerman TS
N Engl J Med; 1983 Jan; 308(1):8-12. PubMed ID: 6401193
[TBL] [Abstract][Full Text] [Related]
20. Defective platelet adhesion on vessel subendothelium in uremic patients.
Castillo R; Lozano T; Escolar G; Revert L; López J; Ordinas A
Blood; 1986 Aug; 68(2):337-42. PubMed ID: 3730605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]